Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Eine Verwendung am Menschen oder als Arzneimittel ist nicht gestattet
Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
categorical variables are expressed as numbers and percentages
Authors contributions Conceived of and designed the article, and critically revised the manuscript (RS, MS), performed critical revision of the manuscript for important intellectual content, obtained funding, and provided administrative, technical and material support (RS), performed literature searches and wrote the manuscript (VRR, KB), updated the text of the manuscript (MS, RS), performed literature searches and table and diagram drawing (JR), critical revision of the manuscript for important intellectual content (AT)